Michael Rawlins
Directeur/Membre du Conseil chez ITI, Inc. (New York)
Profil
Michael Rawlins is currently a Director at UK Biobank Ltd.
and a Director at ITI, Inc. (.
New York).
Previously, he served as the Chairman at Medicines & Healthcare Products Regulatory Agency from 2014 to 2020.
He was also the Chairman at National Institute for Health & Care Excellence from 1999 to 2013.
In addition, he held the position of Independent Director at Intra-Cellular Therapies, Inc. in 2013 and 2014.
Dr. Rawlins has also worked as a Professor at Newcastle University and served as the President of The Royal Society of Medicine from 2012 to 2014.
Postes actifs de Michael Rawlins
| Sociétés | Poste | Début |
|---|---|---|
| ITI, Inc. (New York) | Directeur/Membre du Conseil | 01/06/2021 |
UK Biobank Ltd.
 UK Biobank Ltd. Miscellaneous Commercial ServicesCommercial Services UK Biobank Ltd. is a biomedical database and research resource that contains genetic, lifestyle, and health information from half a million participants aged between 40-69 years in 2006-2010 from across the UK. The organization has over 220 dedicated members of staff, based in multiple locations across the UK. UK Biobank's research resource is a major contributor to the advancement of modern medicine and treatment, enabling better understanding of the prevention, diagnosis, and treatment of a wide range of serious and life-threatening illnesses, including cancer, heart diseases, and stroke. The non-profit company is based in Stockport, UK, and has subsidiaries in the United Kingdom. The database includes blood samples, heart and brain scans, and genetic data that are accessible to approved researchers who are undertaking health-related research that is in the public interest. The CEO of the British company is Rory Collins. | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Rawlins
| Sociétés | Poste | Fin |
|---|---|---|
| Medicines & Healthcare Products Regulatory Agency | Président | 01/01/2020 |
| INTRA-CELLULAR THERAPIES, INC. | Directeur/Membre du Conseil | 31/12/2014 |
The Royal Society of Medicine
 The Royal Society of Medicine Miscellaneous Commercial ServicesCommercial Services The Royal Society of Medicine provides postgraduate medical education. The Society provides a range of educational activities and opportunities for doctors, dentists and veterinary surgeons, including students, and for allied healthcare professionals. It also promotes an exchange of information and ideas on the science, practice and organization of medicine, both within the health professions and with responsible and informed public opinion. The Society was founded in 1805 and is headquartered in London, the United Kingdom. | President | 01/01/2014 |
Intra-Cellular Therapies, Inc. /Old/
 Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Directeur/Membre du Conseil | 26/09/2013 |
National Institute for Health & Care Excellence
 National Institute for Health & Care Excellence Services to the Health IndustryHealth Services National Institute for Health & Care Excellence provides national guidance and advice to improve health and social care. The firm's programs include financial planning, advice, shared learning, standards and indicators and topic selections. The company was founded in 1999 and is headquartered in London, the United Kingdom. | Président | 01/03/2013 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INTRA-CELLULAR THERAPIES, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
The Royal Society of Medicine
The Royal Society of Medicine Miscellaneous Commercial ServicesCommercial Services The Royal Society of Medicine provides postgraduate medical education. The Society provides a range of educational activities and opportunities for doctors, dentists and veterinary surgeons, including students, and for allied healthcare professionals. It also promotes an exchange of information and ideas on the science, practice and organization of medicine, both within the health professions and with responsible and informed public opinion. The Society was founded in 1805 and is headquartered in London, the United Kingdom. | Commercial Services |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Health Technology |
National Institute for Health & Care Excellence
National Institute for Health & Care Excellence Services to the Health IndustryHealth Services National Institute for Health & Care Excellence provides national guidance and advice to improve health and social care. The firm's programs include financial planning, advice, shared learning, standards and indicators and topic selections. The company was founded in 1999 and is headquartered in London, the United Kingdom. | Health Services |
| ITI, Inc. (New York) | |
UK Biobank Ltd.
UK Biobank Ltd. Miscellaneous Commercial ServicesCommercial Services UK Biobank Ltd. is a biomedical database and research resource that contains genetic, lifestyle, and health information from half a million participants aged between 40-69 years in 2006-2010 from across the UK. The organization has over 220 dedicated members of staff, based in multiple locations across the UK. UK Biobank's research resource is a major contributor to the advancement of modern medicine and treatment, enabling better understanding of the prevention, diagnosis, and treatment of a wide range of serious and life-threatening illnesses, including cancer, heart diseases, and stroke. The non-profit company is based in Stockport, UK, and has subsidiaries in the United Kingdom. The database includes blood samples, heart and brain scans, and genetic data that are accessible to approved researchers who are undertaking health-related research that is in the public interest. The CEO of the British company is Rory Collins. | Commercial Services |
| Medicines & Healthcare Products Regulatory Agency | Government |
